The role of dopamine in epilepsy

Synapse

Volumn 22, Issue 2, 1996, Pages 159-194

  Starr, Michael S ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

D1 and D2 receptors; Dopamine; Epilepsy

Indexed keywords

AMANTADINE; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; ANTIPARKINSON AGENT; APOMORPHINE; BROMOCRIPTINE; BUTYROPHENONE DERIVATIVE; CARBIDOPA; CHLORPROMAZINE; CONVULSANT AGENT; DOMPERIDONE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HALOPERIDOL; LEVODOPA; LISURIDE; METHAMPHETAMINE; MONOAMINE OXIDASE B INHIBITOR; NEUROLEPTIC AGENT; PERGOLIDE; PHENOBARBITAL; PHENOTHIAZINE DERIVATIVE; RESERPINE; SELEGILINE; UNINDEXED DRUG;

ANTICONVULSANT ACTIVITY; CLINICAL TRIAL; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC TRANSMISSION; DROWSINESS; DRUG MECHANISM; DRUG SELECTIVITY; EPILEPSY; GASTROINTESTINAL SYMPTOM; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEIZURE; SEIZURE THRESHOLD;

ANIMALS; APOMORPHINE; DISEASE MODELS, ANIMAL; DOPAMINE; EPILEPSY;

EID: 0030045648     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C     Document Type: Review

References (462)

1. Adamec, R.E. (1990) Does kindling model anything clinically relevant? Biol. Psychiatr., 27:249-279.
2. Agarwal, J.C., Nath, C., Gupta, G.P., Bhargava, K.P., and Shanker, K. (1981) Anti-parkinsonian and anticonvulsant activity of some silyl substituted dopamine derivatives. Pharmacol. Res. Commun., 13:937-947.
3. 1 receptors. Eur. J. Pharmacol., 222.227-232.
4. 2 receptors. Neuroscience, 53:425-431.
5. 2--induced epileptiform activity in the rat cingulate cortex slice. Neuroreport, 5:78-80.
6. 3 receptor agonists on pilocarpine-induced limbic seizures in the rat. Neuroscience, 60:1039-1047.
7. 2+-induced epileptiform activity in the rat cingulate cortex slice. Exp. Brain Res., 102:75-83.
8. Albala, B.J., Moshe, S.L., Cubells, J F., Sharpless, N.S., and Makman, M.H (1986) Unilateral peri-substantia nigra catecholaminergic lesion and amygdala kindling. Brain Res., 370:388-392.
9. Alexander, G.J., and Kopeloff, L.M. (1976) Audiogenic seizures in mice: Influence of agents affecting brain serotonin. Res. Commun. Chem. Pathol. Pharmacol., 14:437-448.
10. Alexander, G.J., and Kopeloff, L.M. (1978) Effect of 6-hydroxydopamine. Delayed motor manifestations associated with high mortality in sound-induced seizures in mice. Neurochem. Res , 3:821-825.
11. Alexander, G.J., Kopeloff, L.M., and Alexander, R.B. (1980) 6-hydroxydopamine and metrazol seizures in mice: Inhibition of the tonicclonic phase. Neuropharmacology, 19:679-681.
12. Alexander, G.J., Kopeloff, L.M., and Chatterjee, N. (1985) Convulsive thresholds in mice: Action of 6-hydroxydopamine and eboracin. Exp. Neurol., 89:1-8.
13. Ali, S.F., Jairaj, K., Newport, G.D., Nipe, G.W., and Slikker, W. (1990) Thallium intoxication produced neurochemical alterations in rat brain. Neurotoxicology, 11:381-390.
14. Al-Tajir, G., and Starr, M.S. (1990) Anticonvulsant action of SCH 23390 in the striatum of the rat. Eur. J Pharmacol., 191:329-336.
15. Al-Tajir, G., and Starr, M.S. (1991a) D-2 agonists protect rodents against pilocarpine-induced convulsions by stimulating D-2 receptors in the striatum, but not in the substantia nigra. Pharmacol. Biochem. Behav., 39:109-113.
16. 2 receptor stimulation: Dependence on cortical circuits? Neuroscience, 43:51-57.
17. Al-Tajir, G., and Starr, M.S. (1993) Disordered dopamine neurotransmission in the striatum of rats undergoing pilocarpine-induced generalized seizures, as revealed by microdialysis. J. Neural Transm. Park. Dis. Dement. Sect., 5:89-100.
18. 2 dopamine receptors on the expression of motor seizures in mouse and rat. Neuropharmacology, 29:657-661.
19. 1 receptors. Eur. J. Pharmacol., 182:245-251.
20. Altshuler, H.L., Killam, E.K., and Killam, K.F. (1976) Biogenic amines and the photomyoclonic syndrome in the baboon Papio papio. J. Pharmacol. Exp. Ther., 196:156-166.
21. Anlezark, G.M., and Meldrum, E.S. (1975) Effects of apomorphine, ergocornine and piribedil on audiogenic seizures in DBA/2 mice. Br. J. Pharmacol., 53:419-421.
22. Anlezark, G., and Meldrum, B.S. (1978) Blockade of photically induced epilepsy by "dopamine agonist" ergot alkaloids. Psychopharmacology (Berl.), 57:57-62.
23. Anlezark, G., Pycock, C., and Meldrum, B. (1976) Ergot alkaloids as dopamine agonists: Comparisons in two rodent models. Eur. J. Pharmacol., 37:295-302.
24. Anlezark, G.M., Horton, R.W., and Meldrum, B.S. (1978) Dopamine agonists and audiogenic seizures: The relationship between protection against seizures and changes in monoamine metabolism. Biochem. Pharmacol., 27:2821-2828.
25. Anlezark, G., Marrosu, F., and Meldrum, B. (1981) Dopamine agonists in reflex epilepsy. In: Neurotransmitters, Seizures and Epilepsy. PL. Morselli, K.G. Lloyd, W. Loscher, B. Meldrum, and E.H. Reynolds, eds. Raven Press, New York, pp. 251-259.
26. Anlezark, G.M., Blackwood, D.H.R., Meldrum, B.S., Ram, V.J., and Neumeyer, J.L. (1983) Comparative assessement of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy. Psychopharmacology, 81:135-139.
27. Arias, C., Montiel, T., and Tapia, R. (1990) Transmitter release in hippocampal slices from rats with limbic seizures produced by systemic administration of kainic acid. Neurochem. Res., 15: 641-645.
28. Arnold, P.S., Racine, R.J., and Wise, R.A. (1973) Effects of atropine, reserpine, 6-hydroxydopamine, and handling on seizure development in the rat. Exp. Neurol., 40:457-460.
29. Arushanjan, E.B. (1976) The central monoaminergic mechanisms and generalized convulsions. Z. Neuropathol. Psychiatr. (Moscow), 76: 457-463.
30. Ashton, C., Anlezark, G., and Meldrum, B.S. (1976) Inhibition of reflex epilepsy by (+)-N-n-propylnorapomorphine. Eur. J. Pharmacol., 39:399-401.
31. Ashton, D , Leysen, J.E., and Wauquier, A. (1980) Neurotransmitters and receptor binding in amygdaloid kindled rats; serotoninergic and noradrenergic modulatory effects. Life Sci., 27:1547-1556.
32. 2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine. J. Pharmacol. Exp. Ther., 254:945-951.
33. Azzaro, A.J., Wenger, G.R., Craig, C.R., and Stitzel, R.E. (1972) Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice. J. Pharmacol. Exp. Ther., 180:558-568.
34. Babington, R.G., and Wedeking, P.N. (1973) The pharmacology of seizures induced by sensitization with low intensity brain stimulation. Pharmacol. Biochem. Behav., 1:461-467.
35. Baran, H., Hortnagl, H., and Hornykiewicz, O (1989) Kainic acid-induced seizures: Potentiation by alpha-methyl-p-tyrosine. Brain Res., 495:253-260.
36. Barolin, G.S., and Hornykiewicz, O. (1967) Zur diagnostische Wertigkeit der Homovanilhnsäure im Liquor cerebrospinalis. Wien. Med. Wochenschr., 79:815-818.
37. Barone, P., Parashos, S.A., Palma, V., Marin, C , Campanella, G., and Chase, T.N. (1990) Dopamine D1 receptor modulation of pilocarpine-induced convulsions. Neuroscience, 34:209-218.
38. 2 receptors mediate opposite functions in seizures induced by lithium-pilocarpine. Eur. J. Pharmacol., 195:157-162.
39. Barone, P., Palma, V., DeBartolomeis, A., Cicarelli, G., and Campanella, G. (1992) Dopaminergic regulation of epileptic activity. Neurochem. Int., 20:245S-249S.
40. Barone, P., Morelli, M., Cicarelli, G., Cozzolino, A., DeJoanna, G., Campanella, G., and Di Chiara, G. (1993) Expression of c-fos protein in the experimental epilepsy induced by pilocarpine. Synapse, 14:1-9.
41. Barros, H.M.T., and Leite, J.R. (1986) Effects of acute and chronic carbamazepine administration on apomorphine-elicited stereotypy. Eur. J. Pharmacol., 123:345-349.
42. Barros, H.M.T., Braz, S., and Leite, J.R. (1986) Effect of carbamazepine on dopamine release and reuptake in rat striatal slices. Epilepsia, 27:534-547.
43. Barsa, J.A., and Kline, N.S. (1955) Treatment of two hundred disturbed psychotics with reserpine. JAMA, 158:110-113.
44. Beas-Zarate, C., Arauz-Contreras, J., Velazquez, A., and Feria-Velasco, A. (1985) Monosodium L-glutamate-induced convulsions - II. Changes in catecholamine concentrations in various brain areas of adult rats. Gen. Pharmacol., 16:489-493.
45. Beleslin, D.B., and Krstic, S.K. (1986) Nicotine-induced convulsions in cats and central nicotinic receptors. Pharmacol. Biochem. Behav., 24:1509-1511.
46. Ben-Ari, Y. (1985) Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy. Neuroscience, 14:375-403.
47. Ben-Menachem, E., Persson, L.I., Schechter, P.J., Haegele, KD , Huebert, N., Hardenberg, J., Dahlgren, L., and Mumford, J.P. (1989) The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. Br. J. Clin. Pharmacol., 27 (Suppl.):79S-85S.
48. Bergstrom, D.A., and Kellar, K.J. (1979) Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain Nature, 178:464-466.
49. Bhavsar, V.H., Dhumal, V.R., and Kelkar, V.V. (1981) The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shock to rats. Eur. J. Pharmacol., 74:243-247.
50. Biggs, C.S., Pearce, B.R., Fowler, L.J., and Whitton, P.S. (1992) Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites: An in vivo microdialysis study. J. Neurochem., 59:1702-1708.
51. Bigler, E.D., and Fleming, D.E. (1976) Pharmacological suppression of photically-evoked after-discharges in rats: Incremental dose, hippocampal EEG and behavioral activity correlates. Psychopharmacology, 46:73-82.
52. Bigler, E.D., Fleming, D.E., and Shearer, D.E. (1974) Pharmacological modulation of photically evoked afterdischarge patterns in hooded Long-Evans rats. Bull. Psychon. Soc., 4:179-181.
53. Blackwood, D. (1981) The role of noradrenaline and dopamine in amygdaloid kindling. In: Neurotransmitters, Seizures and Epilepsy. P.L. Morselli, KG. Lloyd, W. Loscher, B.S. Meldrum, and E.H. Reynolds, eds. Raven Press, New York, pp. 203-211.
54. Bo, P., Soragna, D., Marchioni, E., Candeloro, E., Albergati, A., and Savoldi, F. (1995) Role of dopamine D-1 and D-2 antagonists in a model of focal epilepsy induced by electrical stimulation of hippocampus and amygdala in the rabbit. Prog. Neuro-Psychopharmacol. Biol. Psychiatr., 19:917-930.
55. Boggan, W.O., and Seiden, L.S. (1971) Dopa reversal of reserpine enhancement of audiogenic seizure susceptibility in mice. Physiol. Behav., 6:215-217
56. Bondy, S C., Tepper, J.M., and Bettis, D.E. (1979) Seizure proneness and neurotransmitter uptake. Neurochem. Res., 4:755-761.
57. -. Neurosci. Lett., 124:22-26.
58. Bonuccelli, U , Garant, D.S., Maggio, R., and Fariello, R. (1994) Motor expression of kainic acid seizures is attenuated by dopamine depletion in mice. Brain Res., 657:269-274.
59. Borenstein, P., Dabbah, M., and Bles, G. (1962) Etude electroencephalographique de l'haloperidol. Ann. Med. Psychol., 120:133-137.
60. Bormann, J. (1989) Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur. J. Pharmacol., 166: 591-592.
61. Boudouresques, G., Tafani, B , Benichou, M., and Sarlon, R. (1982) Dopamine-induced myoclonic encephalopathy. Semaine des Hopitaux, 58.2729-2730.
62. Bourn, W.M., Chin, L., and Picchioni, A.L. (1972) Enhancement of audiogenic seizure by 6-hydroxydopamine. J. Pharm. Pharmacol., 24:913-914.
63. Bourn, W.M., Chin, L., and Picchioni, A.L. (1977) Effect of neonatal 6-hydroxydopamine treatment on audiogenic seizures. Life Sci., 21:701-706.
64. Bradford, H.F., and Peterson, D.W. (1987) Current views of the pathobiochemistry of epilepsy. Mol. Aspects Med., 9:119-172.
65. 1 dopamine receptors. Br. J. Pharmacol., 86:483-490.
66. Brailowsky, S., and Naquet, R. (1976) Effects of drugs modifying brain levels of catecholamines on photically induced epilepsy in Papio papio. Epilepsia, 17:271-274.
67. Braun, A., Fabrini, G., Mouradain, M.M., Serrati, C., Barone, P., and Chase, T.N (1987) Selective D-1 dopamine receptor agonist treatment of Parkinson's disease. J. Neural Transm., 68:41-50.
68. Brazsko, J.J., Bannon, M.J., Bunney, B S., and Roth, R.H. (1981) Intrastriatal kainic acid: Acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J. Pharmacol. Exp. Ther., 216:289-293.
69. Browning, R.A., and Maynert, E.W. (1978) Effect of intracisternal 6-hydroxydopamine on seizure susceptibility in rats. Eur. J. Pharmacol. 50:97-101.
70. Browning, R.A., and Simonton, R.L. (1978) Antagonism of the anticonvulsant action of phenytoin, phenobarbital and acetazolamide by 6-hydroxydopamine. Life Sci., 22:1921-1929.
71. Burke, K., Chandler, C.J., Starr, B.S., and Starr, M.S. (1990) Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse. Pharmacol. Biochem. Behav., 36:729-733.
72. Burley, E.S., and Ferrendelli, J.A. (1984) Regulatory effects of neurotransmitters on electroshock and pentylenetetrazole seizures. Fed. Proc., 43:2521-2524.
73. Burnham, W.M., King, G.A., and Lloyd, KG. (1981) Extra-focal catecholamine levels in "kindled" rat forebrains. Prog. Neuropsychopharmacol., 5:537-541.
74. Buu, N.T., Duhaime, J., Kuchel, O., and Genest, J. (1981) The convulsive effects of dopamine sulfate conjugates in rat brain. Life Sci., 29:2311-2316.
75. Buzsaki, G., Laszlovszky, I., Lajtha, A., and Vadasz, C. (1990) Spike-and-wave neocortical patterns in rats: Genetic and aminergic control. Neuroscience, 38:323-333.
76. Calderini, G., Carlsson, A., and Nordstrom, C.-H. (1978) Monoamine metabolism during bicuculline-induced epileptic seizures in the rat. Brain Res., 157:295-302.
77. Callaghan, D.A., and Schwark, W.S. (1979) Involvement of catecholamines in kindled amygdaloid convulsions in the rat. Neuropharmacology, 18:541-550.
78. Carlsson, A., Rosengren, E., Bertler, A., and Milsson, J. (1957) Effect of reserpine on the metabolism of catecholamines. In: Psychotropic Drugs. S. Garattini and V Ghetti, eds. Elsevier, Amsterdam, pp. 363-372.
79. Caroff, J., Girin, F., Alix, D., Cann-Moisan, C., Sizun, J., and Barthelemy, I. (1992) Neurotransmission and sudden infant death. Study of cerebrospinal fluid. C. R. Acad. Sci. III, 314:451-454.
80. Cavalheiro, E.A., Fernandes, M.J., Turski, L., and Mazzacoratti, M.G.N. (1991) Neurochemical changes in the hippocampus of rats with spontaneous recurrent seizures. In: Workshop on Neurobiology of Epilepsy. Molecular Neurobiology of Epilepsy. Salvador, Bahia, Brazil, pp. 37-41.
81. Cavalheiro, E.A., Fernandes, M.J., Turski, L., and Naffah-Mazzacoratti, M.G. (1994) Spontaneous recurrent seizures in rats: Amino acid and monoamine determination in the hippocampus. Epilepsia, 33:1-11.
82. Chadwick, D., Gorrod, J.W., Jenner, P., Marsden, C.D., and Reynolds, E.H. (1978) Functional changes in cerebral 5-hydroxytryptamine metabolism in the mouse induced by anticonvulsant drugs. Br. J. Pharmacol., 62:115-124.
83. Chapman, A.G., Croucher, M.J., and Meldrum, B.S. (1984) Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures. Arzneimittelforschung, 34:1261-1264.
84. Chen, G., Ensor, C.R., and Bohner, B. (1954) A facilitation action of reserpine on the central nervous system. Proc. Soc. Exp. Biol. Med., 86:507-510.
85. Chen, G., Ensor, C.R., and Bohner, B. (1968) Studies of drug effects on electrically induced extensor seizures and clinical implications. Arch. Int. Pharmacodyn Ther., 172:183-218.
86. Chu, N.S. (1978) Enhancement of alcohol withdrawal seizures with 6-hydroxydopamine. Epilepsia, 19 603-609.
87. Clark, D., and White, F.J. (1987) Review: D1 dopamine receptor - the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications. Synapse, 1:347-388.
88. Clemens, B. (1988) Dopamine agonist treatment of self-induced pattern epilepsy. A case report. Epilepsy Res., 2.340-343.
89. Coenen, A.M., Drinkenburg, W.H., Inoue, M., and Van Luijtelaar, E.L. (1992) Genetic models of absence epilepsy, with emphasis on the WAG/Rij strain of rats Epilepsy Res., 12:75-86.
90. Cohen, B., and Myerson, A. (1938) The effective use of phenobarbital and benzedrine sulfate (amphetamine sulfate) in the treatment of epilepsy. Am. J. Psychiatr., 95:371-393.
91. Colasanti, B.K., and Craig, C.R. (1973) Brain concentrations and synthesis rates of biogenic amines during chronic cobalt experimental epilepsy in the rat. Neuropharmacology, 12.221-232.
92. Cook, G.H., and Dole, J.A. (1942) A report on the use of phenobarbital and benzedrine sulfate in the treatment of epilepsy. Dis. Nerv. System, 3:366-370.
93. Cools, A.R., Hendriks, G., and Korten, J. (1975) The acetylcholine-dopamine balance in the basal ganglia of rhesus monkeys and its role in dynamic, dystonic, dyskinetic, and epileptoid motor activities. J. Neural Transm., 36:91-105.
94. Corcoran, M.E. (1981) Catecholamines and kindling. In: Kindling. J. Wada, ed. Raven Press, New York, pp. 87-104.
95. Corcoran, M.E., and Mason, S.T. (1980) Role of forebrain catecholamines in amygdaloid kindling. Brain Res., 190:473-484.
96. Corcoran, M.E., Fibiger, H.C., McGeer, E.G., and Wada, J.A. (1973) Potentiation of leptazol seizures by 6-hydroxydopamine. J. Pharm. Pharmacol., 25:497-499
97. Corcoran, M.E., Fibiger, H.C., McCaughran, J.A., and Wada, J.A. (1974) Potentiation of amygdaloid kindling and metrazol-induced seizures by 6-hydroxydopamine in rats. Exp. Neurol., 45:118-133.
98. Cote, T.E., Eskay, R.L., Frey, E.A., Grewe, C.W., Munemura, M., Tsuruta, K., Brown, E.M., and Kebabian, J.W. (1983) Actions of lisuride on adrenoceptors and dopamine receptors. In: Lisuride and Other Dopamine Agonists. D.B. Calne, R. Horowski, R.J. McDonald, and W. Wuttke, eds. Raven Press, New York, pp 45-54.
99. Cox, B., and Lomax, P. (1976) Brain amines and spontaneous epileptic seizures in the Mongolian gerbil. Pharmacol. Biochem. Behav., 4:263-267.
100. Craig, C.R. (1984) Evidence for a role of neurotransmitters in the mechanism of topical convulsant models. Fed. Proc., 43:2525-2528.
101. Critchfield, J.W., Carl, G.F., and Keen, C.L. (1993) The influence of manganese supplementation on seizure onset and severity, and brain monoamines in the genetically epilepsy prone rat. Epilepsy Res., 14:3-10.
102. Csernansky, J.G., Kerr, S., Pruthi, E., and Prosser, E.S. (1988a) Mesolimbic dopamine receptor increases two weeks following hippoeampal kindling. Brain Res., 449:357-360.
103. Csernansky, J.G., Mellentin, J., Beauclair, L., and Lombrozo, L. (1988b) Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala. Biol. Psychiatr., 23:285-294.
104. Dadkar, V.N., Dahanukar, S.A., and Sheth, N.K. (1979) Role of dopaminergic and noradrenergic mechanisms in metrazole convulsions in mice. Indian J. Med. Res., 70:492-494.
105. Dailey, J W., and Jobe, P.C. (1984) Effect of increments in the concentration of dopamine in the central nervous system on audiogenic seizures in DBA/2J mice. Neuropharmacology, 23:1019-1024.
106. Dailey, J.W., Battarbee, H.D., and Jobe, P.C. (1982) Enzyme activities in the central nervous system of the epilepsy-prone rat. Brain Res., 231:225-230.
107. Dailey, J.W., Lesley, S.M., Burger, R L., Bettendorf, A.F., Mishra, P.K., and Jobe, P.C. (1991) Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: Effects of aspartame. Epilepsy Res., 8:122-133.
108. Darney, K.J., Lewis, M.H., Brewster, W.K., Nichols, D.E., and Mailman, R.B. (1991) Behavioral effects in the rat of dihydrexidine, a high-potency, full-efficacy D1 dopamine receptor agonist. Neuropsychopharmacology, 5:187-195.
109. Deakin, J.F.W., Owen, F., Cross, A.J., and Dashwood, M.J. (1981) Studies on possible mechanisms of action of electroconvulsive therapy: Effects of repeated electrically induced seizures on rat brain receptors for monoamines and other neurotransmitters. Psychopharmacology, 73:345-349.
110. Del Zompo, M., Tocco, F., Marrosu, F., Passino, N., and Corsim, G.U. (1983) Increased paroxysmal activity of partial seizures in man by apomorphine. Psychopharmacology (Berl.), 79:209-214.
111. De Montis, G.M., Devoto, P., Gessa, G.L., Meloni, D., Porcella, A., Saba, P , Serra, G., and Tagliamonte, A. (1990) Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants. Eur. J. Pharmacol., 180: 31-35.
112. De Schaepdryver, A.F., Piette, Y., and Delaunois, A.L. (1962) Brain amines and electroshock threshold. Arch. Int. Pharmacodvn., 140:358-367.
113. Di Chiara, G., Porceddu, M.L., Vargiu, L., Argiolas, A., and Gessa, G.L. (1976) Evidence for dopamine receptors mediating sedation in the mouse brain. Nature, 264:564-567.
114. Dongier, S., Dongier, M , Faidherbe, J., and Gastaut, H. (1961) Essai de l'haloperidol dans les troubles mentaux des enfants epileptiques. Presse Med , 69:1191-1193.
115. Doteuchi, M., and Costa, E. (1973) Pentylenetetrazol convulsions and brain catecholamine turnover rate in rats and mice receiving diphenylhydantoin or benzodiazepines. Neuropharmacology. 12:1059-1072.
116. Dow, R.C , Hill, A.G., and McQueen, J.K. (1974) Effects of some dopamine receptor stimulants on cobalt-induced epilepsy in the rat. Br. J. Pharmacol., 52:135P.
117. Dragunow, M., Young, D., Hughes. P., MacGibbon, G., Lawlor, P., Singleton, K., Sirimanne, E., Beilharz, E., and Gluckman, P. (1993) Is c-Jun involved in nerve cell death following status epilepticus and hypoxic-ischemic brain injury? Mol. Brain Res., 18:347-352.
118. 2 dopamine receptors. Neuroscience, 19:125-137.
119. Dusser, A.F., and Peroutka, S.J. (1990) Neurotransmitter receptors in adult tottering (tg/tg) mice. Epilepsia, 31:378-381.
120. Edmonds, H.L., Hegreberg, G.A., Van Gelder, N.M., Sylvester, D.M., Clemmons, R.M., and Chatburn, G.G. (1979) Spontaneous convulsions in beagle dogs. Fed. Proc., 38:2424-2428.
121. El-Etri, M.M., Ennis, M., Jaing, M., and Shipley, M.T. (1993) Pilocarpine-induced convulsions in rats: Evidence for muscarinic receptor-mediated activation of locus coeruleus and norepinephrine release in cholinolytic seizure development. Exp. Neurol., 121:24-39.
122. El-Hamdi, G., Boutroy, M.J., and Nehlig, A. (1992) Effects of pentylenetetrazole-induced seizures on dopamine and norepinephrine levels and on glucose utilization in various brain regions of the developing rat. Int. J. Dev. Neurosci., 10:301-311.
123. Emori, K., Minabe, Y., Tanii, Y., and Kurachi, M. (1991) Effects of chronic treatment with haloperidol and methamphetamine on hippocampal kindled seizures in the cat. Epilepsy Res., 8:213-219.
124. Engel, J., and Sharpless, N.S. (1977) Long-lasting depletion of dopamine in the rat amygdala induced by kindling stimulation. Brain Res., 136:381-386.
125. Euvrard, C., Ferland, L., Di Paolo, T., Beaulieu, M., Labrie, F., Oberlander, C., Raynaud, J.P., and Boissier, J.R. (1980) Activity of two new potent dopaminergic agonists at the striatal and anterior pituitary levels. Neuropharmacology, 19:379-386.
126. Faingold, C.L., and Browning, R.A. (1987) Mechanisms of anticonvulsant drug action. II. Drugs primarily used for absence epilepsy. Eur. J. Paediatr., 146:8-14.
127. Fariello, R.G., DeMattei, M., Castorina, M., Ferraro, T.N., and Golden, G.T. (1987) MPTP and convulsive responses in rodents. Brain Res , 426:373-376.
128. Farjo, I.B., and Blackwood, D.H.R. (1978) Reduction in tyrosine hydroxylase activity in the rat amygdala induced by kindling stimulation. Brain Res., 153:423-426
129. Farjo, I.E., and McQueen, J.K. (1979) Dopamine agonists and cobalt-induced epilepsy in the rat. Br. J. Pharmacol., 67:353-360.
130. Fernando, J.C., Hoskins, B., and Ho, I.K. (1986) The role of dopamine in behavioural supersensitivity to muscarinic antagonists following cholinesterase inhibition. Life. Sci., 39:2169-2176.
131. Ferraro, G., Vella, N., Sardo, P., Caravaglios, G., Sabatino, M., and La Grutta, V. (1991) Dopaminergic control of feline hippocampal epilepsy: A nigrohippocampal pathway. Neurosci. Lett., 123:41-44.
132. Ferrendelli, J.A. (1983) Relationship between seizures and cyclic nucleotides in the central nervous system. Adv. Neurol., 34:353-307.
133. Fisher, R.S. (1989) Animal models of epilepsy. Brain Res. Rev., 14:245-278
134. Fleming, D.E., Rhodes, L.E., Wilson, C.E., and Shearer, D.E. (1972) Time-drug modulations of photically evoked after-discharge patterns. Physiol. Behav., 8:1045-1049.
135. Fochtmann, L.J., Cruciani, R., Aiso, M., and Potter, W.Z. (1989) Chronic electroconvulsive shock increases D-1 receptor binding in rat substantia nigra. Eur. J. Pharmacol., 167:305-306.
136. Fosbraey, P., Wetherell, J.R., and French, M.C. (1990) Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J. Neurochem., 54:72-79.
137. Frey, H.H., Jung, S., and Scherkl, R. (1991) Monoamine turnover in the brain of mice during development of tolerance to the anticonvulsant effect of clonazepam. Epilepsy Res., 8:190-196.
138. Fromm, G.H., Wessel, H.B., Glass, J.D., Alvin, J.D., and Van Horn, G (1978) Imipramine in absence and myoclonic-astatic seizures. Neurology, 28:953-957.
139. Fukushima, R., Yoshida. Y., and Chiba, S. (1990) Long-term effects of postnatal hypoxia on monoamine and amino acid levels in the rat brain. Yakubutsu, 10:335-342.
140. Fuller, R.W. (1986) Biochemical pharmacology of the serotonin system. Adv. Neurol., 43:469-480.
141. Garant, D.S., Iadorola, M.J., and Gale, K. (1986) Substance P antagonists in the substantia nigra are anticonvulsant. Brain Res., 383:372-378.
142. Garelis, E., and Sourkes, T.L. (1973) Factors affecting monoamine metabolite concentrations in the cerebrospinal fluid. Neurology, 23:410.
143. Garelis, E., and Sourkes, T L. (1974) Use of cerebrospinal fluid drawn at pneumoencephalography in the study of monoamine metabolism in man. J. Neurol. Neurosurg. Psychiatr., 37:704-710.
144. Gatterau, A., Vezina, J., Rousseau, S., and Bielmann, P (1990) Hyperprolactinaemia and temporal lobe epilepsy in a woman: Concomitant and persistent prolactin suppression and temporal lobe epilepsy relief. J. Endocrinol. Invest., 13:247-249.
145. Gee, K.W., Hollinger, M.A., Bowyer, J.F., and Killam, E.K. (1979) Effect of seizures kindled by subconvulsant doses of pentylenetetrazol on dopamine receptor binding and dopamine-sensitive adenylate cyclase in the rat. Exp. Neurol., 66:771-777.
146. Gee, K.W., Killam, E.K., Hollinger, M.A., and Giri, S.N. (1980) Effect of amygdaloid kindling on dopamine-sensitive adenylate cyclase activity in rat brain. Exp. Neurol., 70:192-199.
147. Gee, K.W., Killam, E.K., and Hollinger, M.A. (1983) Effects of haloperidol-induced dopamine receptor supersensitivity on kindled-induced seizure development. J. Pharmacol. Exp. Ther., 225:70-76.
148. 2 receptor mRNA expression in basal ganglia following kindling. Epil. Res., 17:23-29.
149. Gerald, M.C., and Riffee, W.H. (1973) Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice. Eur. J. Pharmacol., 21:323-330.
150. Glenthoj, B., Hemmingsen, R., Barry, D.I., Allerup, P., Bruhn, T., and Bolwig, T.G. (1993) Electrical kindling of rats treated discontinuously or continuously with haloperidol. Eur. J. Pharmacol., 236:401-409.
151. Glisson, S.N., Karczmar, A.G., and Barnes, L. (1974) Effects of diisopropyl phosphofluoridate on acetylcholine, cholinesterase and catecholamines of several parts of rabbit brain. Neuropharmacology, 13:623-631.
152. Goldstein, D.S., Nadi, N.S., Stull, R., Wyler, A.R., and Porter, R.J. (1988) Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain. J. Neurochem., 50:225-229.
153. Goodman, L.S., and Gilman, A. (1971) The Pharmacological Basis of Therapeutics. Macmillan, New York.
154. Grace, A.A. (1991) Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24.
155. Gribkoff, V., and Ashe, J. (1984) Modulation by dopamine of population responses and cell membrane properties of hippocampal CA1 neurons in vitro. Brain Res., 292:327-338.
156. 2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus. Neurosci. Lett., 87:253-258.
157. Gross, R.A., and Ferrendelli, J.A. (1979) Effects of reserpine, propranolol and aminophylline on seizure activity and CNS cyclic nucleotides. Ann. Neurol., 6:296-301.
158. Gyoergy, L. (1979) Role of dopaminergic and GABA-ergic interactions in seizure susceptibility. Arch. Int. Pharmacodyn., 241:280-286.
159. Haas, H.L., Jefferys, J.G.R., Slater, N.T., and Carpenter, D.O. (1984) Modulation of low calcium induced field bursts in the hippocampus by monoamines and cholinomimetics. Pflugers Arch., 400:28-33.
160. Habel, A., Yates, C.M., McQueen, J.K., Blackwood, D., and Elton, R A. (1981) Homovanillic acid and 5-hydroxyindoleacetic acid in lumbar - cerebrospinal fluid in children with afebrile and febrile convulsions. Neurology, 31:488-491.
161. Hahn, R.A., Wardell, J.R., Sarau, H.M., and Ridley, P.T. (1982) Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. J. Pharmacol. Exp. Ther., 223: 305-313.
162. Hara, H., Onodera, H., Kato, H., and Kogure, K (1992) Effects of aging on signal transmission and transduction systems in the gerbil brain: Morphological and autoradiographic study. Neuroscience, 46:475-488.
163. Hara, M., Sasa, M., Kawabata, A., Serikawa, T., Yamada, T., Yamada, J., and Takaori, S (1993) Decreased dopamine and increased norepinephrine levels in the spontaneously epileptic rat, a double mutant rat. Epilepsia, 34:433-440.
164. Harrigan, T., Bureau, Y.R.J., Persinger, M.A., and Parker, G.H. (1994) Prevention of sudden cardiac death by the atypical neuroleptic acepromazine following status epilepticus in rats. Life Sci., 54:457-462
165. Helton, D.R., Modlin, D.L., and Williams, P.D. (1992) Behavioral characterization of the new potent nonselective dopamine agonist pergolide. Arzneimittelforschung, 42:885-890.
166. Hiramatsu, M. (1981) Brain monoamine levels and E1 mouse convulsions. Fol. Psychiatr. Neurol. Japon., 35:261-266.
167. Hiramatsu, M., Fujimoto, N., and Mori, A (1982) Catecholamine level in cerebrospinal fluid of epileptics. Neurochem. Res., 7:1299-1305.
168. Holtzbauer, M., and Vogt, M. (1956) Depression by reserpine of noradrenaline concentrations in the hypothalamus of the cat. J. Neurochem , 1:8-11.
169. Home, A.L., Harrison, N.L., Turner, J.P., and Simmonds, M.A. (1986) Spontaneous paroxysmal activity induced by zero magnesium and bicuculline: Suppression by NMDA antagonists and GABA mimetics. Eur. J. Pharamcol., 122:231-238.
170. Huff, M.R., Meadows, G.G., and Johnson, W.E. (1986) Delay of nomifensine-induced seizures by fasaric acid, alpha-methyltyrosine and haloperidol. Res. Commun. Chem. Pathol. Pharmacol., 3:413-416.
171. Hyttel, J. (1983) SCH 23390-the first selective dopamine D-1 receptor antagonist. Eur. J. Pharmacol., 91:153-154.
172. Iadorola, M.J., and Gale, K. (1982) Substantia nigra: Site of anticonvulsant activity mediated by γ-aminobutyric acid. Science, 218: 1237-1240
173. Ishikawa, K., Ott, T., McGaugh, J.L. (1982) Evidence for dopamine as a transmitter in dorsal hippocampus. Brain Res., 232:222-226.
174. Itil, T.M. (1970) Convulsive and anticonvulsive properties of neuropsychopharmaca. In: Modern Problems of Pharmacopsychiatry. E. Niedermeyer, ed. Karger, Basel, pp. 270-276.
175. Ito, M., Okuno, T., Mikawa, H. (1982) Brain monoamine metabolism and 1-dopa therapy of children with intractable epilepsy. Annal. Paediatr. Japon., 28:32-38.
176. Iwakawa, Y., Ogiso, M., Suzuki, H., Kawano, Y., Koyama, J., and Shimohira, M. (1986) Polygraphical study on age dependent epileptic encephalopathy - relationship between body movements during sleep and prognosis. Brain Dev., 8:433-442.
177. Jacome, D.E. (1991) Language-apparent reflex epilepsy. Clin. Electroencephalogr., 22:172-177.
178. Jann, M.W., Grimsley, S.R., Gray, F.C., and Chang, W.H. (1993) Pharmacokinetics and pharmacodynamics of clozapine, Clin. Pharmacokinet., 24:161-176.
179. 2 receptor regulation unilaterally. Soc. Neurosci. Abstr., 17:611.
180. Jefferys, J.G.R. (1990) Basic mechanisms of focal epilepsies. Exp. Physiol., 75:127-162.
181. Jenner, P., and Marsden, C.D. (1979) The substituted benzamides - a novel class of dopamine antagonists. Life Sci., 25:479-486.
182. Jenny, E.H., and Pfeiffer, C.C. (1954) Changes in convulsant threshold after Rauwolfia serpentina, reserpin and veriloid. Fed. Proc., 13:370-371.
183. Jobe, P.C. (1981) Pharmacology of audiogenic seizures. In: The Pharmacology of Hearing: Experimental and Clinical Bases. R.D. Brown and E.A Daigneault, eds. Wiley, New York, pp. 271-304.
184. Jobe, P.C., and Laird, H.E. (1981) Neurotransmitter abnormalities in determinants of seizure susceptibility and intensity in the genetic models of epilepsy. Biochem. Pharmaeol., 30:3137-3144.
185. Jobe, P.C., Picchioni, A., and Chin, L. (1973a) Role of brain norepinephrine in audiogenic seizure in the rat. J. Pharmacol. Exp. Ther., 184:1-10.
186. Jobe, P.C., Picchioni, A., and Chin, L. (1973b) Effect of lithium carbonate and α-methyl-p-tyrosine on audiogenic seizure intensity. J. Pharm. Pharmacol., 25:830-831.
187. Jobe, P.C., Stull, R.E., and Geiger, P.F. (1974) The relative significance of norepinephrine, dopamine and 5-hydroxytryptamine in electroshock seizure in the rat. Neuropharmacology, 13:961-968.
188. Jobe, P.C., Laird, H.E., Ko, K.H., Ray, R., and Dailey, J.W. (1982) Abnormalities in monoamine levels in the central nervous system of the genetically epilepsy prone rat. Epilepsia, 23:359-366.
189. Jobe, P.C., Woods, T.W., and Dailey, J.W. (1983) Central nervous system dopamine but not norepinephrine suppresses audiogenic seizures in DBA/2J mice. Fed. Proc., 42:419.
190. Jobe, P.C., Reigel, C.E., Mishra, P.K., and Dailey, J.W. (1986) Neurotransmitter abnormalities as determinants of seizure predisposition in the genetically epilepsy-prone rat. In: Neurotransmitters, Seizures and Epilepsy 111 G. Nistico, P.L. Morselli, K.G. Lloyd, R.G. Fariello and J. Engel, eds. Raven Press, New York, pp. 387-397.
191. Johnson, D.D., Davis, H.L., and Crawford, R.D. (1979) Pharmacological and biochemical studies in epileptic fowl. Fed. Proc., 38: 2417-2423.
192. Johnson, D.D., Jaju, A.T., Ness, L., Richardson, J.S., and Crawford, R.D. (1981) Brain norepinephrine, dopamine, and 5-hydroxytryptamine concentration abnormalities and their role in the high seizure susceptibility of epileptic chickens. Can. J. Physiol. Pharmacol., 59:144-149.
193. Johnson, K.B., Criswell, H.E., Jensen, K.F., Simson, P.E., Mueller, R.A., and Breese, G.R. (1992) Comparison of the D1-dopamine agonists SKF 38393 and A-68930 in neonatal 6-hydroxydopaminelesioned rats: Behavioral effects and induction of c-fos - like immunoreactivity. J. Pharmacol. Exp. Ther., 262:855-865.
194. Jones, B.J., and Roberts, D.J. (1968) The effects of intracerebroventricularly administered noradnamine and other sympathomimetic amines upon leptazol convulsions in mice. Br. J. Pharmacol., 34:27-31.
195. Kalfakis, N., and Markianos, M (1987) Homovanillic acid and prolactin in plasma and CSF of medicated epileptic patients. Epilepsia, 28:138-141.
196. Kalinowsky, L.B., and Hippius, H. (1969) Pharmacological, Convulsive and Other Somatic Treatments in Psychiatry. Grime and Stratton, New York.
197. Kaneko, S., Okada, M., Hirano, T., Kondo, T., Otani, K., and Fukushima, Y. (1993) Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: Mechanisms of blockade of seizure spread. Jpn. J. Psychiatry Neurol., 47:371-373.
198. Kant, G.J., Meyerhoff, J.L., and Corcoran, M.E. (1980) Release of norepinephrine and dopamine from brain regions of amygdaloidkindled rats. Exp. Neurol., 70:701-705.
199. Karlov, V.A., and Gleizer, M.A. (1983) Reactivity of the system DOPA-dopamine-noradrenaline-adrenaline in epileptic patients. Z. Neuropathol. Psychiatr. (Moscow), 83:810-815.
200. Karoum, F., Korpi, E.R., Chuang, L.W., Linnoila, M., and Wyatt, R.J. (1986) The effects of desipramine, zimelidine, electroconvulsive treatment and lithium on rat brain biogenic amines: A comparison with peripheral changes. Eur J. Pharamcol., 121:377-385.
201. Kellogg, C. (1976) Audiogenic seizures: Relation to age and mechanisms of monoamine neurotransmission. Brain Res., 106:87-103.
202. Kety, S.S., Javoy, F., Thierry, A., Julou, L , and Glowinski, J. (1967) A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc. Natl. Acad. Sci. U.S.A., 58:1249-1254.
203. Kilian, M., and Frey, H.H. (1973) Central monoamines and convulsive thresholds in mice and rats. Neuropharmacology, 12:681-689.
204. Killam, E.K. (1976) Measurement of anticonvulsant activity in the Papio papio model of epilepsy. Fed. Proc., 35:2264-2269.
205. Killam, E.K. (1979) Photomyoclonic seizures in the baboon, Papio papio. Fed. Proc., 38:2429-2433.
206. Killam, E.K., and Killam, K.F. (1984) Evidence for neurotransmitter abnormalities related to seizure activity in the epileptic baboon. Fed. Proc., 43:2510-2515.
207. Killam, E.K., Matsuzaki, M., and Killam, K.F. (1973) Studies of anticonvulsant compounds in the Papio papio model of epilepsy. In: Chemical Modulation of Brain Function. H. Sabelli, ed. Raven Press, New York, pp. 161-171.
208. Killam, K.F., Killam, E.K., and Naquet, R. (1966) Études pharmacologiques réalisés chez des singes présentant une activité EEG paroxystique particulière a la stimulation lumineuse intermittente. J. Physiol. (Paris), 58:543-544.
209. Kimura, D. (1962) Multiple response of the visual cortex of the rat to photic stimulation. Electroencephalogr. Clin. Neurophysiol., 14: 115-122.
210. King, G.A., and Burnham, W.M. (1980) Effects of d-amphetamine and apomorphine in a new animal model of petit mal epilepsy. Psychopharmacology, 69:281-285.
211. King, J.T., and LaMotte, C.C. (1989) El mouse as a model of focal epilepsy: A review. Epilepsia, 30:257-265.
212. Klee, M.R. (1982) Die Wirkung von Memantin auf Membraneigenschaften und postsynaptische Potentiale von Nervenzellen der Aplysia californica. Arzneimittelforschung, 32:1259-1267.
213. Kleinrok, Z., Czuczwar, S.J., Wojcik, A., and Przegalinski, E. (1978) Brain dopamine and seizure susceptibility in mice. Pol. J. Pharmacol. Pharm., 30:513-519.
214. Kleinrok, Z., Czuczwar, S.J., Kozicka, M., and Zarkowski, A. (1981) Effect of combined GABAergic and dopaminergic stimulation on the action of some antiepileptic drugs in pentylenetetrazol-induced convulsions. Pol. J. Pharamcol., 33:13-23.
215. Ko, K.H., Jobe, P.C., Dailey, J.W., Ray, T.B., and Friedman, T.T. (1981) The role of noradrenergic transmission in the antieonvulsant effect of L-DOPA and iproniazid in epilepsy-prone rats. Fed. Proc., 40:311.
216. Ko, K.H., Dailey, J.W., and Jobe, P C. (1982) Effect of increments in norepinephrine concentrations on seizure intensity in the genetically epilepsy-prone rat. J. Pharmacol. Exp. Ther., 222:662-369.
217. Kobayashi, K., and Mori, A. (1977) Brain monoamines in seizure mechanism (review). Folia Psyehiatr. Neurol. Jap., 31:483-489.
218. 2 receptors in the rat hippocampal region. Neurosci. Lett., 126:107-109.
219. Kokaia, M., Kalen, P., Bengzon, J., and Lindvall, O. (1989) Noradrenaline and 5-hydroxytryptamine release in the hippocampus during seizures induced by hippocampal kindling stimulation. An in vivo microdialysis study. Neuroscience, 32:647-656.
220. Kornhuber, J., Bormann, J., Hubers, M., Rusche, K., and Riederer, P. (1991) Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gaied ion channel: A human postmortem brain study. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.), 206: 297-300.
221. Koslow, S.H., and Roth, L.J. (1971) Reserpine and acetazolamide in maximum electroshock seizure in the rat. J. Pharmacol. Exp. Ther., 176:711-717.
222. Kresch, M.J., Shaywitz, B.A., Shaywitz, S.E., Anderson, G.M., Leekman, J.L., and Cohen, D.J. (1987) Neurotransmitters in human epilepsy. In: Neurotransmitters and Epilepsy. P.C. Jobe and H.E. Laird, eds. Humana Press, New York. pp. 321-338.
223. La Grutta, V., and Sabatino, M. (1990) Substantia nigra-mediated anticonvulsant action: A possible role of a dopaminergic component. Brain Res., 515:87-93.
224. La Grutta, V., Amato, G., and Zagami, M.T. (1971) The importance of the caudate nucleus in the control of convulsive activity in the amygdaloid complex and the temporal cortex of the cat. Eleetroencephalogr. Clin. Neurophysiol., 31:57-69.
225. Laird, H.E. (1983) Abnormal concentrations and turnover rates of norepinephrine and dopamine in brains of genetically seizure-susceptible rats. Epilepsia, 24:107.
226. Laird, H.E. (1989) The genetically epilepsy-prone rat. A valuable model for the study of the epilepsies. Mol Chem. Neuropathol., 11:40-59.
227. Laird, H.E., Dailey, J.W., and Jobe, P.C. (1984) Neurotransmitter abnormalities in genetically epileptic rodents. Fed. Pro., 43:2505-2509.
228. Lal, S. (1988) Apomorphine in the evaluation of dopaminergic function in man. Progr. Neuropsychopharmacol. Biol Psychiatry, 12: 117-164.
229. Lalonde, R. (1985) Dopaminergic supersensitivity after long-term administration of phenytoin in rats. Epilepsia, 26:81-84.
230. Lamprecht, F. (1977) Epilepsy and schizophrenia: A neurochemical bridge. J. Neural Transm., 40:159-170.
231. Landolt, H. (1958) Serial electroencephalographic investigations during psychotic episodes in epileptic patients and during schizophrenic attacks. In: Lectures in Epilepsy. L. de Haas, ed. Elsevier, Amsterdam, pp. 91-133.
232. Lannes, B., Vergnes, M., Marescaux, C., DePaulis, A., Micheletti, G., Warter, J.M., and Kempf, E. (1991) Lesions of noradrenergic neurons in rats with spontaneous generalized non-convulsive epilepsy. Epilepsy Res., 9:79-85.
233. Lapin, I.P., and Ryzov, I.V. (1990) Effect of catecholaminergic drugs on quinolinate- and kynurenme-indueed seizures in mice. J. Neural. Transm. Gen. Sect., 82:55-65.
234. Laxer, K.D., Sourges, T.L., Fang, T.Y., Young, S.N., Gauthier, S.G., and Missala, K (1979) Monoamine metabolites in the CSF of epileptic patients. Neurology, 29:1157-1161.
235. Lazarova, M., and Roussinov, K. (1979) On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice. Acta Physiol. Pharmacol. Bulg., 5:67-74.
236. Lazarova, M., and Samanin, R. (1983) Serotonin mediation of the protective effect of clonidine against pentylenetetrazol-induced seizures in rats. Life Sci., 32:2343-2348.
237. Lazarova, M., Bendotti, C., and Samanin, R. (1983) The role of different types of adrenergic receptors in pentylenetetrazol-induced seizures and the effect of di-n-propylacetate in the rat. Psychopharmacolog, 81:177-182.
238. Leach, M J., Baxter, M G., and Critchley, M.A. (1991) Neurochemical and behavioral aspects of lamotrigine. Epilepsia, 32 (Suppl.):S4-S8.
239. Legeza, V.I., Shagoian, M.G., Kaminina, M.F., and Markovska, P.V. (1982) Effect of catecholaminergic drugs on pentylenetetrazol-induced seizures in rat. Pharmacol. Toxicol. (Moscow), 45:19-23.
240. Lehmann, A. (1967) Audiogenic seizures data in mice supporting new theories of biogenic amines mechanism in the central nervous system. Life Sci., 6:1423-1431.
241. Lehmann, A. (1977) Mechanisms underlying modifications in the severity of audiogenic convulsions. Life Sci., 20-2047-2060.
242. Leino. O. (1981) Open trial with levodopa-carbidopa combination to patients with long-standing progressive myoclonus epilepsy. Acta Neurol. Scand., 63:389-395.
243. Lepore, V, Di Reda, N., DeFazio, G., Pedone, D., Giovine, A., Lanzi, C., Tartaglione, B., and Livrea, P. (1985) Dopaminomimetic action of diphenylhydantoin in rat striatum: Effect on homovanillic acid and cyclic AMP levels. Psychopharmacology, 86:27-30.
244. Lerer, B., Jabotinsky-Rubin, B , Bannet, J., Ebstein, R., and Belmaker, R.H. (1982) Eleetroconvulsive shock prevents dopamine receptor supersensitivity. Eur. J. Pharmacol., 80:131-134.
245. Lessin, A.W , and Parks, M.W. (1959) The effects of reserpine and other agents upon leptazol convulsions in mice. Br. J. Pharmacol., 14:108-111.
246. Lewis, J., Westerberg, V., and Corcoran, M.E. (1987) Monoaminergic correlates of kindling. Brain Res., 403:205-212.
247. Lhermitte, F., Marteau, R., and Degos, C.F. (1972) Analyse pharmacologique d'un nouveau cas de myoclonies d'intention et d'action post-anoxiques. Rev. Neurol., 126:107-114.
248. Lipka, L.J., and Lathers, C.M. (1987) Psyehoactive agents, seizure production and sudden death in epilepsy. J. Clin. Pharmacol., 27:169-183.
249. Livingston, S., Kadji, L , and Bridge, E.M. (1948) The use of benzedrine and dexedrine sulphate in the treatment of epilepsy. J. Paediatr., 32:490-494.
250. Livingston, S., Herman, W., and Pauli, L.L. (1973) Amphetamines in epilepsy. Pediatrics, 52:753-754.
251. Livrea, P. (1976) Dosaggio di acido omovanillico e di acido 5-idrossindolacetico liquorali in disturbi del sonno, epilessia, corea degenerative e vasculopatie cerebrale acute. Acta Neurol., 31:588-600
252. Livrea, P., Di Reda, L., and Papagna, G. (1976) Livelli liquorali di HVA e di 5-HIAA in soggetti epilettici: Effetto della privazione totale di sonno. Acta Neurol., 31:632-636.
253. Lloyd, K.G., Scatton, B., Voltz, C., Briere, P., Valin, A., and Naquet, R. (1986) Amino acid and monoamine metabolite levels in the CSF of Papio papio: Correlation with photosensitive response. In: Neurotransmitters, Seizures and Epilepsy 111. G. Nistico, P.L. Morselli, K.G. Lloyd, R.G. Fariello, and J. Engel, eds. Raven Press, New York, pp. 151-161.
254. Logothetis, J. (1955) Desoxyn therapy for nocturnal seizures. Neurology, 5:236-241.
255. Logothetis, J. (1967) Spontaneous epileptic seizures and electroencephalographic changes in the course of phenothiazine therapy. Neurology, 17:869-877.
256. London, E.D., and Buterbaugh, G.G. (1978) Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction. J. PharmacoL., Exp. Ther., 206:81-90
257. London, E.D., Waller, S.B., Vocci, F.J., and Buterbaugh, G.G. (1982) Age-dependent reduction in maximum electroshock convulsive threshold associated with decreased concentrations of brain monoamines. Pharmacol. Biochem. Behav., 16:441-447.
258. Löscher, W. (1985) Influence of pharmacological manipulation of inhibitory and excitatory neurotransmitter systems on seizure behavior in the mongolian gerbil. J. Pharmacol. Exp. Ther., 233:204-213.
259. Loscher, W., and Czuczwar, S.J. (1986) Studies on the involvement of dopamine D-1 and D-2 receptors in the anticonvulsant effect of dopamine agonists in various rodent models of epilepsy. Eur. J. Pharmacol., 128:55-65.
260. Loscher, W., and Honack, D. (1990) High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats. Naunyn-Schmiedeb. Arch. Pharmacol., 341:476-481.
261. Louw, D., Sutherland, G.R , Glavin, G.B., and Girvin, J. (1989) A study of monoamine metabolism in human epilepsy. Can. J. Neurol. Sci., 16:394-397.
262. Maitre, M., Hechler, V., Vayer, P., Gobaille, S., Cash, C.D., Schmitt, M., and Bourguignon, J.J. (1990) A specific gamma-hydroxybutyrate receptor ligand possesses both antagonistic and anticonvulsant properties. J. Pharmacol. Exp. Ther., 255:657-663.
263. Maj. J. (1982) Die Wirkung von Memantin auf zentrale Neurotransmittersysteme. Eine Zusammenfassung der Ergebnisse. Arzneimittelforschung, 32.1256-1259.
264. Maj, J., Sowinska, H., Baran, L., and Sarnek, J. (1974) Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative. Eur. J. Pharmacol., 26:9-14.
265. Marescaux, C., Vergnes, M., Depaulis, A. (1992) Genetic absence epilepsy in rats from Strasbourg - a review. J. Neural Transm , 35:37-69.
266. Markianos, M., and Kalfakis, N. (1991) Neurotransmitter metabolites in medicated epileptic patients. Funct. Neurol., 6:367-370.
267. Marrannes. R., and Wauquier, A. (1988) Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Inhibition by anticonvulsants. Pharmacol. Biochem. Behav., 31:153-162.
268. Marrosu, F., Del Zompo, M., and Corsini, G.U. (1983) The role of dopamine in human epilepsy: Effect of apomorphine. Prog. Clin. Biol. Res., 124:95-104.
269. Martin, G.E., Williams, M., Pettibone, D.J., Yarbrough, G.G., Chneschmidt, E.V., and Jones, J.H. (1984) Pharmacologic profile of a novel potent direct-acting dopamine agonist, (+)-4-propyl-9-hydroxy-naphthoxazine [(+)-PHNO]. J. Pharmacol. Exp. Ther, 230:569-576
270. Mason, S.T., and Corcoran, M.E. (1978) Forebrain noradrenaline and metrazol-induced seizures. Life Sci., 23:167-172.
271. Mason, S.T., and Corcoran, M.E. (1979) Depletion of brain noradrenaline but not dopamine, by intracerebral 6-hydroxydopamine potentiates convulsions induced by electroshock J. Pharm. Pharmacol., 31:209-211.
272. Matthews, R.T., and German, D.C. (1986) Evidence for a functional role of dopamine type-1 (D1) receptors in the substantia nigra of rats. Eur. J. Pharmacol., 120:87-93.
273. Mauro, A.M., Scarpino, O., and Pelliccioni, G. (1986) Dopaminergic treatment in a case of Lafora's disease. Boll. Lega Ital. Control Epil., 54-55:63-65.
274. Maynert, E.W., Marczynski, T.J., and Browning, R.A. (1975) The role of the neurotransmitters in the epilepsies. Adv. Neurol., 13:79-147.
275. McGarvey, K.A., Zis, A.P., Brown, E.E., Nomikos, G.G., and Fibiger, H.C. (1993) ECS-induced dopamine release: Effects of electrode placement, anticonvulsant treatment, and stimulus intensity. Biol. Psychiatr., 34:152-157.
276. McIntyre, D.C., Saari, M., and Pappas, B.A. (1979) Potentiation of amygdala kindling in adult or infant rats by injections of 6-hydroxydopamine. Exp. Neurol., 63:527-544.
277. McKenzie, G.M., and Soroko, F.E. (1972) The effects of apomorphine, (+)-amphetamine and L-DOPA on maximal electroshock convulsions - a comparative study in the rat and mouse. J. Pharm. Pharmacol., 24:696-701.
278. McKenzie, G.M., and Soroko, F.E (1973) Inhibition of the anticonvulsant activity of L-dopa by FLA-63, a dopamine-β-hydroxylase inhibitor. J. Pharm. Pharmacol., 25:76-77.
279. McLean, M.J., Dettbarn, W.D., and Gupta, R.C. (1987) Anti-convulsant properties of memantine. Neurology, 37:350-351.
280. McMillen, B.A., and Isaac, L. (1978) Relationship between kindled myoclonic seizures and feline brain dopamine metabolism. Brain Res., 150:424-430.
281. McNamara, J.O. (1984) Role of neurotransmitters in seizure mechanisms in the kindling model of epilepsy. Fed. Proc., 43.2516-2520.
282. McNamara, J.O. (1994) Cellular and molecular basis of epilepsy. J. Neurosci., 14:3413-3425.
283. Meduna, L. (1935) Versuche über die biologische Beeinflussung des Ablaufes der Schizophrenie. Zeit. Ges. Neurol. Psychiatr., 152: 235-262.
284. Meldrum, B.S. (1978) Neurotransmitters and epilepsy. In: Neurotransmitter Systems and Their Clinical Disorders. N.J. Legg, ed. Academic Press, New York, pp. 164-180.
285. Meldrum, B.S. (1988) Initiation and neuroanatomical spread of seizure activity. In: Recent Advances in Epilepsy. T.A. Pedley and B.S. Meldrum, eds. Churchill Livingstone, London, pp. 1-19.
286. Meldrum, B.S. (1990) Anatomy, physiology, and pathology of epilepsy. Lancet, 336:231-234.
287. Meldrum, B.S., Balzano, E., Wada, J.A., and Vuillon-Cacciuttolo, G. (1972) Effects of L-tryptophan, L-3,4-dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio. Physiol. Behav., 9: 615-621.
288. Meldrum, B., Anlezark, G., and Trimble, M. (1975a) Drugs modifying dopammergic activity and behaviour, the EEG and epilepsy in Papio papio. Eur, J. Pharmacol., 32:203-213.
289. Meldrum, B.S., Chir, B., and Horton, R.W. (1975b) A primate model for testing anticonvulsant drugs. Arch. Neurol., 32:289-294.
290. Meldrum, B.S., Anlezark, G., Balzano, E., Horton, R.W., and Trimble, M. (1975c) Photically induced epilepsy in Papio papio as a model for drug studies. Adv. Neurol., 10:119-128.
291. Meldrum, B.S., Turski, L., Schwarz, M., Czuczwar, S.J., and Sontag, K.H. (1986) Anticonvulsant action of 1,3-dimethyl-5-ammoadamantane. Pharmacological studies in rodents and baboon, Papio papio. Naunyn-Schmiedeb. Arch. Pharmacol., 332:93-97.
292. Menkes, J.H. (1973) Committee on drugs attacked. Pediatrics, 53:952.
293. Mervaala, F., Andermann, F., Quesney, I.E., and Krelina, M. (1990) Common dopaminergic mechanism for epileptic photosensitivity in progressive myoclonus epilepsies. Neurology, 40:53-56.
294. Mialon, P., Caroff, J., Barthelemy, I., and Bigot, J.C. (1990) Ammonia and monoamine concentrations in two brain areas in rats after one hyperoxic seizure. Aviat. Space Environ. Med., 61:28-32.
295. Michelson, H.B., and Buterbaugh, C.G. (1985) Amygdala kindling in juvenile rats following neonatal administration of 6-hydroxydopamine. Exp. Neurol., 90:588-593.
296. Millichap, J.G. (1968) Drugs in management of hyperkinetic and perceptually handicapped children. JAMA, 206:1527-1530.
297. Minabe, Y., Tami, Y, and Kurach, M. (1987) Acute effect of some psychotropic drugs on low-frequency amygdaloid kindled seizures. Biol. Psychiatr., 22:1444-1450.
298. Minabe, Y., Emori, K., and Kurachi, M. (1988a) Effects of chronic treatment with methamphetamine and imipramine on amygdaloid seizure's generation. Jpn. J. Psychiatry Neurol., 42:337-343.
299. Minabe, Y, Tstutsumi, M., and Kurachi, M. (1988b) Effects of chronic haloperidol treatment on amydaloid seizure generation in cats. Psychopharmacology, 94:259-262.
300. Minamoto, Y., Itano, T., Tokuda, M., Matsui, H., Janjua, N.A., Hosokawa, K., Okada, Y., Murakami, T.H., Negi, T., and Hatase, O. (1992) In vivo microdialysis of amino acid neurotransmitters in the hippocampus in amygdaloid kindled rat. Brain Res., 573:345-348.
301. Mintz, M , and Herberg, L.J. (1986) Endogenous dopaminergic asymmetry affects development of seizures kindled in the rat amygdala. Exp. Neurol., 93:253-260.
302. Mintz, M., Tomer, R., Houpt, S., and Herberg, L.J. (1987) Amygdala kindling modifies interhemispheric dopaminergic asymmetry. Exp. Neurol., 96:137-144.
303. 14C]acetylcholine release from the rat prefrontal cortex and striatal slices. Brain Res., 592:115-121.
304. Mizoguchi, K., Yokoo, H., Yoshida, M., Tanaka, T., and Tanaka, M. (1994) Amantadine increases the extracellular dopamine levels in the striatum by re-uptake inhibition and by N-methyl-D-aspartate antagonism. Brain Res., 662:255-288.
305. Morgan, W.W. (1976) Effect of 6-hydroxydopamine pretreatment on spontaneous convulsions induced by barbital withdrawal. Experientia, 32:480-491.
306. Mori, A., Hiramatsu, M., Kabuto, H., and Marescaux, B. (1986) Effects of emotional stress on El-mouse convulsions, and their biochemical background. Neurochem. Res., 11:37-45.
307. Mori, A., Hiramatsu, M., Namba, S., Nishimoto, A., Ohmoto, T., Mayanagi, Y., and Asakura, T. (1987) Decreased dopamine level in the epileptic focus. Res. Commun. Chem. Pathol. Pharmacol., 56: 157-164.
308. Morimoto, K., and Goddard, G.V. (1986) Kindling induced changes in the EEG recorded during stimulation from the site of stimulation: Collapse of GABA-mediated inhibition of onset of rhythmic synchronous burst. Exp. Neurol., 94:571-584.
309. Morimoto, K., Morikawe, T., Akiyama, T., Sato, M., and Otsuki, S. (1983) Anticonvulsant effect of a novel TRH analog (DN-1417) on amygdaloid kindles seizures. Brain and Nerve, 35:189-195.
310. Morimoto, T., Hayakawa, T., Sugie, H., Awaya, Y., and Fukuyama, Y. (1985) Epileptic seizures precipitated by constant light, movement in daily life, and hot water immersion. Epilepsia, 26:237-242.
311. Mutani, R. (1969) Experimental evidence for the existence of an extrarhinencephalic control of the activity of the cobalt rhinencephalic epileptogenic focus. Part 1. The role played by the caudate nucleus. Epilepsia, 10:337-350.
312. Nagai. Y., Narumi, S., Saji, Y., and Nagawa, Y. (1985) ATRH analogue (DN-1417): Anti-reserpine action on electroconvulsive threshold and involvement of serotoninergic (5-HT) mechanism in mice. Folia Pharmacol. Jap., 85:221-230.
313. Nakamura, J., Yamada, S., Mine, K (1984) The effect of anticonvulsants on the electroconvulsive threshold: Different response to GABA and dopamine-inhibitory systems. Folia Psychiatr. Neurol. Jap., 38:197-200.
314. Naquet, R., and Meldrum, B.S. (1972) Photogenic seizures in the baboon. In: Experimental Models of Epilepsy. D.P. Purpura, J.K. Penry, D.M. Woodbury, D.E. Tower, and R.D. Walter, eds. Raven Press, New York, pp. 374-406.
315. Neuman, R.S. (1986) Suppression of penicillin-induced epileptiform activity by noxious stimulation: Mediation by 5-hydroxytryptamine. Electroencephogr. Clin. Neurophysiol., 64:546-555.
316. N'Gouemo, P., Lerner-Natoli, M.L., Rondouin, G., Watanabe, K., Sandillon, F., Privat, A., and Baldy-Moulinier, M.B. (1990) Catecholaminergic systems and amygdala kindling development. Effects of bilateral lesions of substantia nigra dopaminergic or locus coeruleus noradrenergic neurones. Epil. Res., 5:92-102.
317. Nielsen, H., and Kristensen, O. (1981) Personality correlates of sphenoidal EEG-foci in temporal lobe epilepsy. Acta Neurol. Scand., 64:289-300
318. Nieto-Barrera, M., Candau, R., Rufo, M., Vaquero, F., and Jimenez, L. (1988) Catecholaminergic and serotoninergic neurotransmitters between seizures in rolantic epilepsy. Boll. Lega Ital. Contro Epil., 62-63:275-277.
319. Nomikos, G.G., Zis, A.P., Damsma, G., and Fibiger, H.C. (1991a) Eleetroconvulsive shock produces large increases in the interstitial concentrations of dopamine in the rat striatum: An in vivo microdialysis study Neuropsychopharmacology, 4:65-69.
320. Nomikos, G.G., Zis, A.P., Damsma, G., and Fibiger, H.C. (1991b) Effects of chronic electroconvulsive shock on interstitial concentrations of dopamine in the nucleus accumbens. Psychopharmacology, 105: 230-238.
321. Nowak, G., and Zak, J. (1989) Repeated electroconvulsive shock (ECS) enhances striatal D-1 dopamine receptor turnover in rats. Eur. J. Pharmacol., 167:307-308.
322. Obeso, J.A., Rothwell, J.C., Quinn, N.P., Lang, A.E., Thomson, C., and Marsden, C.D. (1983) Cortical reflex myoclonus responds to intravenous hsuride. Clin. Neuropharmacol., 6:231-240.
323. Obeso, J.A., Artieda, J., Tunon, T., Luquin, M.R., and Martinez Lage, J M. (1985) Dopamine agonists suppress visual-cortical reflex myoclonus. J. Neurol. Neurosurg. Psychiatr., 48:1277-1283.
324. Ogren, S.O., and Pakh, B. (1993) Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice. Pharmacol. Toxicol., 72:213-220.
325. Ohmori, T., Nakamura, F., Koyama, T., and Yamashita, I. (1992) Amygdala kindling does not alter the N-methyl-D-aspartate receptorchannel complex which modulates dopamine release in the rat striaturn and amygdala. Brain Res., 587:207-262.
326. Oishi, R., Suenaga, N., and Fukada, T. (1979) Possible involvement of brainstem norepinephrine in pentylenetetrazole convulsions in rats. Pharmacol. Biochem. Behav., 10:57-66.
327. 2+ dependent dopamine release. Epilepsy Res., 13:113-119.
328. Ono, K, Mori, K., Baba, H., and Wada, J.A. (1987) A role of the striatum in premotor cortical seizure development. Brain Res., 435:84-90.
329. Osuide, G., Wambebe, C., and Ngur, D. (1983) Studies on the pharmacology of d-amphetamine on maximal electroconvulsive seizure in young chicks. Psychopharmacology, 81:119-121.
330. Pakalnis, A., Drake, M.E., John, K., and Kellum, J.B. (1987) Forced normalization. Acute psychosis after seizure control in seven patients. Arch. Neurol., 44:289-292.
331. Pallister, P.D. (1959) Aggravation of epilepsy by reserpine, associated with possible bleeding and clotting disturbances. Rocky Mt. Med. J., 56:45-50.
332. Papeschi, R., Molina-Negro, P., Sourkes, T.L., and Erba, G. (1972) The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Neurology, 22:1151-1159.
333. Pfeiffer, A.K., and Galambos, E. (1967) The effect of reserpine, α-methyl-m-tyrosine, prenylamine and guanethidine on metrazol convulsions and the brain monoamine level in mice. Arch. Int. Pharmacodyn., 165:210-211.
334. Pintor, M., Mefford, I.N., Hutter, I., Pocotte, S.L., Wyler, A.R., and Nadi, S. (1990) Levels of biogenic amines, their metabolites, and tyrosine hydroxylase activity in the human epileptic temporal cortex. Synapse, 5:152-156.
335. Pletscher, A., Shore, P.A., and Brodie, B.B. (1955) Serotonin release as a possible mechanism of reserpine action. Science, 122:374-378.
336. Pollack, D.C. (1987) Models for understanding the antagonism between seizures and psychosis. Progr. Neuropsychopharmacol. Biol. Psychiatr., 11:483-504.
337. 3H]SCH 23390 binding sites in the rat substantia nigra: Evidence for a presynaptic localization and innervation by dopamine. Life Sci., 39:321-328.
338. Porter, R.J. (1988) New antiepileptic drugs: Prospects for improved treatment of seizures. In: Recent Advances in Epilepsy. T.A. Pedley and B.S. Meldrum, eds. Churchill Livingstone, New York, pp. 161-179.
339. Prockop, D.J., Shore, P.A., and Brodie, B.B. (1959) Anticonvulsant properties of monoamine oxidase inhibitors. Ann. N. Y. Acad. Sci., 80:643-651.
340. Przegalinski, E. (1980) Monoamines and pathophysiology of seizure disorders. In: Handbook of Experimental Pharmacology, Antiepileptic Drugs. H.H Frey and D. Janz, eds. Springer, Berlin, 74:101-137.
341. Quattrone, A., Crunelli, V., and Samanin, R. (1978) Seizure susceptibility and anticonvulsant activity of carbamazepine, diphenylhydantoin and phenobarbital in rats with selective depletions of brain monoamines. Neuropharmacology, 17:643-647.
342. Quesney, L.F. (1981) Dopamine and generalized photosensitive epilepsy. In: Neurotransmitters, Seizures and Epilepsy. P.L. Morselli, KG. Lloyd, W. Löscher, B. Meldrum, and E.H. Reynolds, eds. Raven Press, New York, pp. 263-274.
343. Quesney, L.F. (1984) Pathophysiology of generalized photosensitive epilepsy in the cat. Epilepsia, 25:61-69.
344. Quesney, L.F., Andermann, F., Lal, S., and Prelevic, S. (1980) Transient abortion of generalized photosensitive epileptic discharge in humans by apomorphine, a dopamine-receptor agonist. Neurology, 30:1169-1174.
345. Quesney, L.F., Andermann, F., and Gloor, P. (1981) Dopaminergic mechanism in generalized photosensitive epilepsy. Neurology, 31:1542-1544.
346. Rada, P., and Hernandez, L. (1990) Opposite changes of dopamine turnover in prefrontal cortex and nucleus accumbens after amygdaloid kindling. Neurosci. Lett., 117:144-148.
347. Rao, M.L., Stefan, H., and Bauer, J. (1989) Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinologj, 49:33-39.
348. Ray, S.K., and Poddar, M.K. (1985) Effect of pentylenetetrazol on carbaryl-induced changes in striatal catecholamines. Biochem. Pharmacol., 34:553-557.
349. Reader, T.A., De Champlain, J., and Jasper, H.H. (1976) Catecholamines released from cerebral cortex in the cat: Decrease during sensory stimulation. Brain Res., 111:95-108.
350. Reader, T.A., Ferron, A., Descarries, L., and Jasper, H.H. (1979) Modulatory role for biogenic amines in the cerebral cortex. Microiontophoretic studies. Brain Res., 160:217-229.
351. Renming, X., Ishihara, K., Sasa, M., Ujihara, H., Momiyama, T., Fujita, Y., Todo, N., Serikawa, T., Yamada, J., and Takaori, S. (1992) Antiepileptic effects of CNK-602A, a novel thyrotropin-releasing hormone analog, on absence-like and tonic seizures of spontaneously epileptic rats. Eur. J. Pharmacol., 223:185-192.
352. Reynolds, E.H. (1981) Biological factors in psychological disorders associated with epilepsy. In: Epilepsy and Psychiatry. E.H. Reynolds and M.R. Trimble, eds. Churchill Livingstone, London, pp. 264-290.
353. Reynolds, E.H., Chadwick, D., and Jenner, P. (1975) Folate and monoamine metabolism in epilepsy. J. Neurol. Sci., 26:605-615.
354. Riekkinen, P.J., Pitkanen, A., Ylinen, A., Sivenius, J., and Halonen, T. (1989) Specificity of vigabatrin for the GABAergic system in human epilepsy. Epilepsia, 30 (Suppl.):S18-S22.
355. Riffee, W.H., and Gerald, M.C. (1976) Effects of amphetamine isomers and CNS catecholamine blockers on seizures in mice. Neuropharmacology, 15:677-682.
356. Riffee, W.H., and Gerald, M.C. (1977) The effects of chronic administration and withdrawal of (+)-amphetamine on seizure threshold and endogenous cateeholamine concentrations and their rates of biosynthesis in mice. Psychopharmacology, 51:175-179.
357. Riffee, W.H., Wilcox, R.E., Goldman, C.P.L., and Smith, R.V. (1981) Effects of apomorphine and piribedil on pentylenetetrazol-induced seizures in mice. Psychopharmacology, 75:391-394.
358. Ring, H.A., Trimble, M R., Costa, D.C., George, M.S., Verhoeff, P., and Ell, P. J. (1992) Effect of vigabatrin on striatal dopamine receptors: Evidence in humans for interactions of GABA and dopamine systems. J. Neurol. Neurosurg. Psychiatr, 55:758-761.
359. Ring, H.A., Trimble, M.R., Costa, D.C., Moriarty, J., Verhoeff, N.P.L.G., and Ell. P.J. (1994) Striatal dopamine receptor binding in epileptic psychoses. Biol. Psychiatr., 35:375-380.
360. Ritz, M.C., and George, F.R. (1993) Cocaine-induced seizures and lethality appear to be associated with distinct central nervous system binding sites. J. Pharmacol. Exp. Ther., 264:1333-1343.
361. Robertson, H.A. (1992) Dopamine receptor interactions: Some implications for the treatment of Parkinson's disease. Trends Neurosci., 15:201-206.
362. Roth, R.H. (1976) Striatal dopamine and gamma-hydroxybutyrate. Pharmacol. Ther., 2:71-88.
363. Rothstein, J.D., and Tabakoff, B. (1982) Effects of the convulsant methionine sulfoxime on striatal dopamine metabolism. J. Neurochem., 39:452-457.
364. Ryan, L.J. (1985) Catecholamine regulation of neoeortical spindling in DBA/2 mice. Behav. Brain Res., 16:103-115.
365. Ryzov, I.V., and Lapin, I.P. (1985) Similarities and dissimilarities of the test-convulsants pentylenetetrazole and picrotoxin in pharmacological experiment. In: Pharmacology of Neurotropic Drugs. Saratov, pp. 84-98.
366. Sabatino, M., Caravaglios, G., and La Grutta, V. (1988) Nigral control of hippocampal epilepsy: a dopaminergic hypothesis. Pharmaeol. Res. Commun., 20:1109-1110.
367. Sabatino, M., Gravante, G., Ferraro, G., Vella, N., La Grutta, G., and La Grutta, V. (1989) Striatonigral suppression of focal hippocampal epilepsy. Neurosci. Lett., 98:285-290.
368. Sandoval, M.R.L., and Palermo-Neto, J. (1989) Behavioural aspects of GABAergie-dopammergic interactions in the central nervous system. Eur. J. Pharmacol., 167:117-125.
369. Sasa, M., Ohno, Y., Ujihara, H., Fujita, Y., Yoshimura, M., Takaori, S., Serikawa, T., and Yamada, J. (1988) Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. Epilepsia, 29:505-508.
370. Sato, M., Tomoda, T., Hikasa, N., and Otsuki, S. (1980) Inhibition of amygdaloid kindling by chronic pretreatment with cocaine or methamphetamine. Epilepsia, 21:497-507.
371. Satoh, H., Nakanishi, H., Shirakawa, K, Kohjimoto, Y., Kuwaki, T., Ono, T., and Shibayama, F. (1987) Comparative study of tiapride and neuroleptics with anti-dopamine activity on convulsive seizure in mice. Jpn. J. Pharmacol., 43:27-32.
372. Savoldi, F., Tartara, A., and Bo, P. (1979) Dopamine-agonist drugs and cerebral electrical activity in the rabbit. Farmaco, 34:526-534
373. Scatton, B., Simon, H., Le Moal, M., and Bischoff, S. (1980) Origin of dopaminergic innervation of the rat hippocampal formation. Xeurosci. Lett., 18:125-131.
374. Schonfeld, A.R., and Glick, S.D. (1980) Neuropharmacologieal analysis of handling-induced seizures in gerbils. Neuropharmacology, 19:1009-1016.
375. Schlesinger, K., Boggan, W., and Griek, B. (1968) Pharmacogenetic correlates of pentylenetetrazol and electroconvulsive seizure thresholds in mice. Psychopharmacologia (Berl.), 13:181-188.
376. Seeman, P. (1981) Brain dopamine receptors. Pharmacol. Rev., 32: 229-313.
377. Sekimoto, M., Ushijima, I., Mizuki, Y., and Yamada, M. (1992) The threshold lowering effects of chronic treatment with haloperidol on beta-carboline derivative-induced tonic convulsion. Yakabutsu, 12:121-127.
378. Semba, J., Doheny, M., Patsalos, P.N., Sarna, G., and Curzon, G. (1992) Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex. Brit. J. Pharmacol., 105:59-62.
379. Serikawa, T., Ohno, Y., Sasa, M., Yamada, J., and Takaori, A. (1987) A new model of petit mal epilepsy: Spontaneous spike and wave discharges in tremor rats. Lab. Anim., 21:68-71.
380. Setler, P.E., Sarau, H.M., Zirkle, C.L., and Saunders, H.L. (1978) The central effects of a novel dopamine agonist. Eur. J. Pharmacol., 50:419-130.
381. Sharp, T., Kingston, J., and Grahame-Smith, D.G. (1990) Repeated ECS enhances dopamine D-1 but not D-2 agonist-induced behavioural responses in rats Psychopharmacology, 100:110-114.
382. Shaywitz, B.A., Cohen, D.J., and Bowers, M.B. (1975) Reduced cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in children with epilepsy. Neurology, 25:72-79.
383. Shaywitz, B.A., Yager, R.D., and Gordon, J. W. (1978) Ontogeny of brain catecholamine turnover and susceptibility to audiogenic seizures in DBA/2J mice. Dev. Psychobiol., 11:243-250
384. Shields, W.D., Lake, J.L., and Chugani, H.T. (1985) Amantadine in the treatment of refractory epilepsy in childhood. An open trial in 10 patients. Neurology, 35:579-581.
385. Silverstein F., and Johnston, M.V. (1984) Cerebrospinal fluid monoamine metabolites in patients with infantile spasms. Neurology, 34:102-105.
386. Smialowski, A. (1990) Inhibition of low calcium induced epileptiform discharges in the hippocampus by dopamine D1 receptor agonist, SKF 38393. Brain Res., 528:148-150.
387. Smialowski, A., and Bijak, M. (1987) Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors. Neuroscience, 23:95-101.
388. Snead, O.C. (1983) On the sacred disease: The neurochemistry of epilepsy. Int. Rev. Neurobiol., 24:93-180.
389. Snead, O.G. (1987) Noradrenergic mechanisms in γ-hydroxybutyrateinduced seizure activity. Eur. J. Pharmacol., 136:103-108.
390. 3) as a target for neuroleptics. Nature, 347:146-151.
391. Soroko, F.E., and McKenzie, G.M. (1970) The effects of ape-morphine and dexamphetamine on metrazol-induced convulsions in the rat and mouse. Pharmacologist, 12:253.
392. Spanagel, R., Eilbacher, B., and Wilke, R. (1994) Memantine-induced dopamine release on the prefrontal cortex and striatum of the rat - a pharmacokinetic microdialysis study. Eur J. Pharmacol., 262-21-26.
393. Spehlmann, R., and Norcross, K. (1984) Decreased sensitivity of neurons in the basolateral amygdala to dopamine and noradrenaline iontophoresis after a kindling stimulus. Exp. Neurol., 83:204-210.
394. Spencer, P.S.J., and Turner, T.A.R. (1969) Blockade of biogenic amine synthesis: Its effect on the responses to leptazol and dexamphetamine in rats. Br. J. Pharmacol., 37-94-103.
395. Sperk, G., Lassmann, H., Baran, H., Kish, S.J., Seitelberger, F., and Hornykiewicz, O. (1983) Kainic acid induced seizures: Neurochemical and histopathological changes. Neuroscience, 10:1301-1315.
396. Stach, R., and Kacz, D. (1977) Effect of combined dopaminergic and GABA-ergic stimulation on ouabain-induced epileptiform activity. Epilepsia, 18:417-423.
397. Starr, B.S., Starr, M.S., and Kilpatrick, I.C. (1987) Behavioural role of dopamine D-1 receptors in the reserpine-treated mouse. Neuroscience, 22:179-188.
398. 3H]-γ-ammobutyric acid release? J. Neurochem., 49: 1042-1049.
399. 2 Dopamine Receptor Interactions. J. Waddington, ed. Academic Press, New York, pp. 235-269.
400. Starr, M.S., and Starr, B.S. (1993a) Glutaxnate-dopamine interactions in the production of pilocarpine motor seizures in the mouse. J. Neural Transm. Park. Dis. Dement. Sect., 6:109-117.
401. 1 agonists does not correlate with other dopaminergic properties. J. Neural Transm. Park. Dis. Dement. Sect., 6:27-34.
402. Starr, M.S., and Starr, B S. (1993c) Paradoxical facilitation of pilocarpine-induced seizures in the mouse by MK-801 and the nitric oxide synthesis inhibitor L-NAME. Pharmacol. Biochem. Behav., 45: 321-325.
403. Stevens, J.R. (1980) Biologic background of psychoses in epilepsy. In: Advances in Epileptology. R. Canger, F. Angeleri, and J.K. Penry, eds. Raven Press, New York, pp. 167-172.
404. Stevens, J.R. (1991) Psychosis and the temporal lobe. Adv. Neurol., 55:79-96.
405. Stock, G., Kummer, P., Stumpf, H., Zenner, H., and Sturm, V. (1983) Involvement of dopamine in amygdaloid kindling. Exp. Neurol., 80:439-400.
406. Stockmaier, C.A., and Blask, D.E. (1986) Neuropharmacological modification of central catecholamines: Effects on pinealectomy-indueed convulsions. J. Pineal Res., 3:67-76.
407. Stockmaier, C.A., Larsen, B.R., and Blask, D.E. (1985) Alteration of seizures resulting from pinealectomy in the rat after neonatal treatment with 6-hydroxydopamine. J. Neurosci. Res., 14:279-284.
408. Strauss, H. (1944) The effect of mental activity on the incidence of seizures and the electroencephalographic pattern in some epileptics. With remarks on the influence of amphetamine sulfate. Psychosom. Med., 6:141-145.
409. Strecker, R.E., and Moneta, M.E. (1994) Electrical stimulation of the kindled hippocampus briefly increases extracellular dopamine in the nucleus accumbens. Neurosci. Lett., 176:173-177.
410. Stull, R.E., Jobe, P.C., Geiger, F.F., and Fergusson, G.G. (1973) Effects of dopamine receptor stimulation and blockade on Ro 4-1284-induced enhancement of electroshock seizure. J. Pharm. Pharmacol., 25:842-844.
411. Stull, R.E., Jobe, P.C., and Geiger, P.F. (1977) Brain areas involved in the catecholamine mediated regulation of electroshock intensity. J. Pharm. Pharmacol., 29:8-11.
412. Suppes, T., Knegstein, A.R., and Prince, D.A. (1985) The influence of dopamine on epileptiform burst activity in hippocampal pyramidal neurons. Brain Res., 326:273-280.
413. Sutoo, D., Akiyama, K., and Takita, H. (1987) The relationship between metal ion levels and biogenic amine levels in epileptic mice. Brain Res , 418:205-213.
414. Sutoo, D., Akiyama, K., and Takita, H (1990) Effect of intraventrieular administration of calcium on the lowering of brain dopamine level in epileptic mice. Epilepsy Res., 6:199-204.
415. Suzuki, S., and Mori, A. (1992) Regional distribution of tyrosine, tryptophan, and their metabolites in the brain of epileptic E1 mice. Neurochem. Res., 17:693-698.
416. Tabakoff, B., Yanai, J., and Ritzman, R.F. (1978) Brain noradrenergic systems as a prerequisite for developing tolerance to barbiturates. Science, 200:449-451.
417. Taylor, D.C. (1972) Mental state and temporal lobe epilepsy. Epilepsia, 13:727-765.
418. Toone, B. (1981) Psychoses of epilepsy. In: Epilepsy and Psychiatry. E.H. Reynolds and M.R Trimble, eds. Churchill Livingstone, London, pp. 113-137.
419. Trimble, M. (1977) The relationship between epilepsy and schizophrenia: A biochemical hypothesis. Biol. Psychiatr., 12:299-304.
420. Trimble, M. (1978) Non-monoamine oxidase inhibitor anti-depressants and epilepsy: A review. Epilepsia, 19:241-250.
421. Trimble, M.R., and Meldrum, B.S. (1979) Monoamines, epilepsy and schizophrenia. In: Biological Psychiatry Today. J. Obiols, E. Ballus, M. Gonzales and J. Pujol, eds. Elsevier, Amsterdam, pp. 470-475.
422. Trimble, M.R., Meldrum, B.S., and Anlezark, G. (1977) Effect of nomifensine on brain amines and epilepsy in photosensitive baboons. Br. J. Clin. Pharmacol , 4 (Suppl.):101S-107S.
423. Tsuda, H., Ito, M., Oguro, K., Mutoh, K., Shiraishi, H., Shirasaka, Y., and Mikawa, H (1993) Age- and seizure-related changes in noradrenaline and dopamine in several brain regions of epileptic El mice. Neurochem Res., 18-111-117.
424. 2 dopamine receptor. Nature, 292:463-465.
425. Turski, L., Cavalheiro, E.A., Bortolotto, Z.A., Ikonomidou-Turski, C., Kleinrok, Z., and Turski, W.A. (1988) Dopamine-sensitive anticonvulsant site in the rat striatum. J. Neurosci., 8:3837-3847.
426. Turski, L., Ikonomidou, C., Turski, W.A., Bortolotto, Z.A., and Cavalheiro, E.A. (1989) Review: Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: A novel experimental model of intractable epilepsy. Synapse, 3:154-171
427. Turski, W.A., Czuczwar, S.J., Kleinrok, Z., and Turski, L. (1983) Cholinomimetrics produce seizures and brain damage in rats. Experientia, 39:1408-1411.
428. Turski, W.A., Cavalheiro, E.A., Ikonomidou, C., Bortolotto, Z.A., Klockgether, T., and Turski, L. (1990) Dopamine control of seizure propagation. Intranigral dopamine D1 agonist SKF 38393 enhances susceptibility to seizures. Synapse, 5:113-119.
429. Ujihara, H., Renming, X., Sasa, M., Ishihara, K., Fujita, Y. Yoshimura, M., Kishimoto, T., Serikawa, T., Yamada, J., and Takaori, S. (1991) Inhibition by thyrotropin-releasing hormone of epileptic seizures in spontaneously epileptic rats. Eur. J. Pharmacol., 196-15-19.
430. Van Ness, P.C., Olsen, R.W., and Verity, M.A. (1989) MPTP is proconvulsant acutely but has no long-term effect in rodent models of seizure and epilepsy. Brain Res., 504:289-292.
431. 4 receptor with high affinity for the antipsychotic chozapine. Nature, 350:610-614.
432. Van Woert, M.H., and Sethy, V.H. (1975) Therapy of intention myoclonus with L-5-hydroxytryptophan and a peripheral decarboxylase inhibitor, MK 486. Neurology, 25:135-140.
433. Van Woert. M.H., Rosenbaum, D., Howieson, J., and Bowers, M.B. (1977) Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa. N. Engl. J. Med., 296:70-75.
434. Veliskova, J., Velisek, L., Mares, P., Rokyta, R., and Budko, K.P. (1991) Bicuculline-induced neocortical epileptiform foci and the effects of 6-hydroxydopamine in developing rats. Brain Res. Bull., 26:693-698.
435. Verney, C., Baulack, M., Berger, B., Alvarez, C., Vigny, A., and Helle, K. (1985) Morphological evidence for a dopaminergic terminal field in the hippocampal formation of young and adult rat. Neuroscience, 14:1039-1042.
436. Volkman, P.H., Lorens, S.A., Kindel, G.H., and Ginos, J.Z. (1978) L-5-hydroxytryptophan-induced myoclonus in guinea pigs: A model for the study of central serotonin-dopamine interactions. Neuropharmacology, 17:947-955.
437. Vriend. J., Alexiuk, N.A., Green-Johnson, J., and Ryan, F. (1993) Determination of amino acids and monoamine neurotransmitters in caudate nucleus of seizure-resistant and seizure-prone BALB/c mice. J. Neurochem., 60:1300-1307.
438. Wada, J.A. (1977) Pharmacological prophylaxis in the kindling model of epilepsy. Arch. Neurol., 34:389-395.
439. 2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats. Brain Res., 553:181-187
440. Waldmeier, P.C., Baumann, P.A., Fehr, B., De Herdt, P., and Maitre, L. (1984) Carbamazepine decreases catecholamine turnover in the rat brain. J. Pharmacol. Exp. Ther., 231:166-172.
441. Waller, S.B., and Buterbaugh, G.G. (1985) Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development. Pharmacol. Biochem. Behav., 23:473-478.
442. Walters, J.R., Bergstrom, D.A., Bromley, S.D., Wasczak, B.L., and Jackson, D.M. (1983) Neurophysiological effects of dopamine agonists in the substantia nigra and globus pallidus Acta Pharm. Suecica (Suppl.), 1:186-199.
443. Wambebe, C., and Osuide, G. (1983) Influence of dopamine on strychnine-induced seizures in the domestic fowl (Gallus domesticus). Gen. Pharmacol., 14:295-297.
444. Wambebe, C., and Osuide, G. (1984) Influence of dopamine, levodopa and apomorphine on maximal electroconvulsive seizure in the domestic fowl (Gallus domesticus). Jap. J. Pharmacol., 35:339-346.
445. Wambebe, C., Osuide, G., and Gamaniel, K. (1984) Influence of levodopa. apomorphine and 3,4-dihydroxyphenylserine (DOPS) on strychnine-induced seizures in mice. Gen. Pharmacol., 15:243-245.
446. Warter, J.-M., Vergnes, M., DePaulis, A., Tranchant, C., Rumbach, L., Micheletti, G., and Marescaux, C. (1988) Effects of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology, 27:269-274.
447. Weaving, A., Bezwoda, W.R., and Derman, D.P. (1984) Seizures after antiemetic treatment with high dose domperidone: Report of four cases. Br. Med. J., 288:1728.
448. Weiner, W.J., Carvey, P.M., Nausieda, P.A., and Klawans, H.L. (1979) Dopaminergic antagonism of L-5-hydroxytryptophan-induced myoclonic jumping behaviour. Neurology, 29:1622-1625.
449. Welch, K.M.A., Wang, T.P.F., and Chabi, E. (1978) Ischemic-induced seizures and cortical monoamine levels. Ann. Neurol., 3:152-155.
450. Wenger, G.R., Stitzel, R.E., and Craig, C.R. (1973) The role of biogenic amines in the reserpine-induced alteration of minimal electroshock seizure thresholds in the mouse. Neuropharmacology, 12:693-703.
451. Whitton, P.S., Biggs, C S , Pearce, B.R., and Fowler, L. J. (1992) Regional effects of MK-801 on dopamine and its metabolites studied by in vivo microdialysis. Neurosci. Lett., 142:5-8.
452. Wilcox, R.E., Riffee, W.H., Goldman, C.P.L., and Young, R.K. (1984) Effects of ascorbate on a dopaminergic response: Apomorphine-induced modification of pentylenetetrazol-induced seizures in mice. Psychopharmacology, 83:48-40.
453. Wilkison, D.M., and Halpern, L.M. (1979) Turnover kinetics of dopamine and norepinephrine in the forebrain after kindling in rats. Neuropharmacology, 18:219-222.
454. Wolf, P. (1985) Forced normalization. In: Aspects of Epilepsy and Psychiatry. M.R. Trimble and T.G. Bolwig, eds. Wiley. Chichester, pp. 101-115.
455. Wolf, P., and Trimble, M.R. (1985) Biological antagonism and epileptic psychosis. Br. J. Psychiatr., 146:272-276.
456. Woods, T.W., Jobe, P.C., Laird, H.E., and Dailey, J.W. (1983) Anticonvnilsant and proconvulsant doses of desipramine in the genetically epilepsy-prone rats. Fed. Proc., 42:363.
457. Wurpel, J.N.D., Dundore, R.L., Balaban, C.D., Keil, L.C., and Severs, L.N.B. (1985) Vasopressin-induced seizures (barrel rotation) after lesions of substantia nigra and basal ganglia. Fed. Proc., 44:5721.
458. Yan, Q.S., Jobe, P.C., and Dailey, J.W. (1993) Thalamic deficiency in norepinephrine release detected via intracerebral microdialysis A synaptic determinant of seizure predisposition in the genetically epilepsy-prone rat. Epilepsy Res., 14:229-236.
459. Yokoi, I , Yamamoto, M., Fujikawa, N., Shirasu, A., and Mori, A. (1986) Determination of neurotransmitter release into the caudate nucleus during convulsions induced by pentylenetetrazole using in vivo differential pulse voltammetry. Brain Res., 385:212-218.
460. Yoshimura, Y., Dohi, T., Tanaka, S., Tanaka, K., and Tsujimoto, A. (1991) Changes in convulsion susceptibility of lidocaine by alteration of brain catecholaminergic functions. Jap. J. Pharmacol , 56:85-91.
461. Zimmer, R., Teelken, A.W., and Gunderewa, M. (1980) Effect of sodium valproate on CSF GABA, cAMP, cGMP and homovanillic acid levels in men. Brain Res. Bull., 5 (Suppl. 2):585-588.
462. Zis, A.P., Nomikos, G.G., Damsma, G., and Fibiger, H.C (1991) In vivo neurochemical effects of electroconvulsive shock studies by microdialysis in the rat striatum. Psychopharmacology, 103:343-350.